Increased trend of breast cancer mortality in Iran

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 1, 2012, Pages 367-370

  Taghavi, Afsoon ^a   Fazeli, Zeinab ^a   Vahedi, Mohsen ^b   Baghestani, Ahmad Reza ^c   Pourhoseingholi, Asma ^a   Barzegar, Farnoosh ^a   Pourhoseingholi, Mohamad Amin ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Breast cancer; Burden; Iranian females; Mortality

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; IRAN; MIDDLE AGED; MORTALITY; PROGNOSIS; SURVIVAL RATE; TIME;

ADOLESCENT; ADULT; AGE FACTORS; BREAST NEOPLASMS; FEMALE; HUMANS; IRAN; MIDDLE AGED; MORTALITY; PROGNOSIS; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 84864865195     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.1.367     Document Type: Article

References (46)

1. Ahmad O, Boschi Pinto C, Lopez AD, et al (2001). Age standardization of rates: a new WHO standard. Geneva, World Health Organization.
2. Akbari ME (2008). Iran cancer report. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Qom: Darolfekr.
3. Autier P, Boniol M, Gavin A, et al (2011). Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ, 28, 343-?.
4. Botha JL, Bray F, Sankila R, et al (2003). Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer, 39, 1718-29.
5. Bulliard JL, La Vecchia C, Levi F (2006). Diverging trends in breast cancer mortality within Switzerland. Ann Oncol, 7, 57-9.
6. Choi Y, Kim Y, Park SK, et al (2006). Age-Period-Cohort Analysis of Female Breast Cancer Mortality in Korea. Breast Cancer, 13, 266-71.
7. Das B, Feuer EJ, Mariotto A (2005). Geographic association between mammography use and mortality reduction in the US. Cancer Causes Control, 16, 691-9.
8. Elmore JG, Armstrong K, Lehman CD, et al (2005). Screening for breast cancer. JAMA, 293, 1245-56.
9. Forbes JF (1997). The incidence of breast cancer: the global burden, public health considerations. Semin Oncol, 24, 20-35.
10. Fracheboud J, Otto SJ, Van Dijck JA, et al (2004). Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer, 91, 861-7.
11. Harirchi I, Ebrahimi M, Zamani N, et al (2000). Breast cancer in Iran: a review of 903 case records. Public Health, 114, 143-5.
12. Harirchi I, Karbakhsh M, Kashefi A, et al (2004). Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev, 5, 24-7.
13. Harirchi I, Kolahdoozan S, Karbakhsh M, et al (2011). Twenty years of breast cancer in Iran: downstaging without a formal screening program. Ann Oncol, 22, 93-7.
14. He M, Guo Q, Hu G (2011). Reversed urban-rural differences in breast cancer mortality (China, 2002-2008). Breast Cancer Res Treat, 126, 231-4.
15. Hery C, Ferlay JM, Boniol M, et al (2009). Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol, 19, 1187-94.
16. Hirte L, Nolte E, Bain C, et al (2007). Breast cancer mortality in Russia and Ukraine 1963-2002: an age-period-cohort analysis. Int J Epidemiol, 36, 900-6.
17. Hoerger TJ, Ekwueme DU, Miller JW, et al (2011). Estimated Effects of the National Breast and Cervical Cancer Early Detection Program on Breast Cancer Mortality. Am J Prev Med, 40, 397-404.
18. IARC (2002). Globocan 2002 Database. Mortality. Available at http://wwwdep.iarc.fr/.
19. IzquierdoA, GispertR, Saladie F, et al (2008). Analysis of cancer incidence, survival and mortality according to the main tumoral localizations, 1985-2019: Breast cancer. Med Clin (Barc), 131, 50-2.
20. Katanoda K, Yako Suketomo H (2010). Comparison of Time Trends in Breast Cancer Mortality (1990-2006) in the World, from the WHO Mortality Database. Jpn J Clin Oncol, 40, 182-?.
21. Kogevinas M, Pearce N, Susser M, et al (1997). Social inequalities and cancer. Lyon. IARC Scientific Publications no. 138.
22. Kono A, Misumi J, Misumi J (2005). The time trend of breast cancer mortality in Japan. Arch Gynecol Obstet, 272, 187-90.
23. Levi F, Bosetti C, Lucchini F, et al (2005). Monitoring thePrev, 14, 497-502.
24. Marks NF, Shinberg DS (1998). Socioeconomic status differences in hormone therapy. Am J Epidemiol, 148, 581-93.
25. Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, et al (2009). Cancer Incidence in Tehran Metropolis: The First Report from the Tehran Population-Based Cancer Registry, 1998 - 2001. Arch Iran Med, 12, 15-23.
26. Montazeri A, Vahdaninia M, Harirchi I, et al (2008). Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods. Asia Pac Fam Med, 7, 6-?.
27. Moore MA, Eser S, Igisinov N, et al (2010). Cancer epidemiology and control in North-Western and Central Asia - past, present and future. Asian Pac J Cancer Prev, 11, 17-32.
28. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
29. Mousavi SM, Mohaghegghi MA, Mousavi-Jerrahi A, et al (2006). Burden of breast cancer in Iran: a study of the Tehran population based cancer registry. Asian Pac J Cancer Prev, 7, 571-4.
30. Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91.
31. Naghavi M (2002). Death report from 18 provinces in Iran. 1st edition. Ministry of Health and Medical Education, Tehran, Iran.
32. Naghavi M (2003). Death report from 18 provinces in Iran. 1st edition. Ministry of Health and Medical Education, Tehran, Iran.
33. Naghavi M (2004). Death report from 18 provinces in Iran. 1st edition. Ministry of Health and Medical Education, Tehran, Iran.
34. Naghavi M, Abolhassani F, Pourmalek F, et al (2003). The burden of disease and injury in Iran 2003. Popul Health Metr, 15, 7-9.
35. Park SK, Kim Y, Kang D, et al (2011). Risk factors and control strategies for the rapidly rising rate of breast cancer in Korea. J Breast Cancer, 14, 79-87.
36. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
37. Parkin DM, Whelan SL, Ferlay J, et al (1997). Cancer incidence in five continents, vol. VII. Lyon. IARC Scientific Publications no. 143.
38. Sadjadi A, Nouraie M, Mohagheghi MA, et al (2005). Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev, 6, 359-63.
39. Shamsa AZ, Mohagheghi MA (2002). Final report of the National project for cancer registry. Islamic Republic of Iran.
40. Threlfall AG, Collins S, Woodman CB (2003). Impact of NHS breast screening on advanced disease and mortality from breast cancer in the North West of England. Br J Cancer, 89, 77-80.
41. U.S. Cancer Statistics Working Group (2010). U.S. Cancer Statistics: 2005 Incidence and Mortality. Atlanta GA: USDHHS, CDC and National Cancer Institute, www.cdc.gov/uscs.
42. Wilson CM, Tobin S, Young RC (2004). The exploding worldwide cancer burden: the impact of cancer on women. Int J Gynecol Cancer, 14, 1-11.
43. World Health Organization (2009). Mortality database. WHO, , 2-6.
44. World Health Organization: Cancer (2008). [http://www.who.int/mediacentre/factsheets/fs297/en]. accessed 30.07.
45. Yavari P, Pourhoseingholi MA (2007). Socioeconomic factors association with knowledge and practice of breast self-examination among Iranian women. Asian Pac J Cancer Prev, 8, 618-22.
46. Zheng W, Shu XO, McLaughlin JK, et al (1993). Occupational physical activity and the incidence of cancer of the breast, corpus uteri, and ovary in Shanghai. Cancer, 71, 3620-4.